A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects with Disability Following an ischemic Stroke (PISCES III)
Clinical Trial Grant
Administered By
Neurology, General & Community Neurology
Awarded By
ReNeuron Group plc
Start Date
April 2, 2019
End Date
June 30, 2021
Administered By
Neurology, General & Community Neurology
Awarded By
ReNeuron Group plc
Start Date
April 2, 2019
End Date
June 30, 2021